Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick

    Editors Pick - Page 13

    CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database

    CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database

    Farhat Nasim11 Dec 2019 2:41 PM IST
    CDSCO is preparing a comprehensive database of sites and investigators involved in the conduct of the clinical trial in different therapeutic...
    With Vildagliptin off-patent from today, new doors open for pharma players

    With Vildagliptin off-patent from today, new doors open for pharma players

    Farhat Nasim10 Dec 2019 12:47 PM IST
    New Delhi: The expiry of Swiss-drugmaker Novartis's blockbuster anti-diabetic drug Vildagliptin is being a bringer of glad tidings for Indian Pharma...
    CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

    CDSCO directs Veterinary manufacturers to submit Periodic Safety Reports every 6 months for first 2 years

    Farhat Nasim9 Dec 2019 12:12 PM IST
    The direction to submit PSURs came after various stakeholders of Veterinary products raised a concern regarding the clarification with respect to...
    Govt action against BioMed contaminated polio vaccine supply; Minister informs RS

    Govt action against BioMed contaminated polio vaccine supply; Minister informs RS

    Farhat Nasim8 Dec 2019 11:30 AM IST
    New Delhi: The Minister in the Ministry of Health and Family Welfare, Ashwini Kumar Choubey recently informed the Parliament about the action taken by...
    Take action against chemists selling prescription drugs OTC sans authorization: HC directs Govt

    Take action against chemists selling prescription drugs OTC sans authorization: HC directs Govt

    Medical Dialogues Bureau7 Dec 2019 10:07 AM IST
    The petition had alleged that chemists dealing in the retail sale of medicines are selling antibiotics and medicines mentioned in Schedule H and H1 of...
    How to make Medical Devices Affordable- Minister apprises Lok Sabha

    How to make Medical Devices Affordable- Minister apprises Lok Sabha

    Farhat Nasim6 Dec 2019 3:00 PM IST
    New Delhi: Through a written reply, the Minister in the Ministry of Chemicals and Fertilizers D V Sadananda Gowda recently apprised the Parliament...
    Only Retail, NOT online pharmacies eligible to deliver medicines at a customer

    Only Retail, NOT online pharmacies eligible to deliver medicines at a customer's residence; Draft guidelines

    Medical Dialogues Bureau6 Dec 2019 9:09 AM IST
    Retail pharmacies still home deliver drugs in their respective areas, but if the revised regulations get enforced, they would be allowed to do in a...
    Govt puts a FULL STOP on E-pharmacies running without licences, directs necessary action

    Govt puts a FULL STOP on E-pharmacies running without licences, directs necessary action

    Farhat Nasim5 Dec 2019 12:55 PM IST
    New Delhi: The apex drug regulatory body, Central Drugs Standard Control Organisation's (CDSCO) recently issued orders to impose a ban on unlicensed...
    Eris Lifesciences acquires diabetes drug trademark Zomelis from Novartis AG for India for Rs 93 crore

    Eris Lifesciences acquires diabetes drug trademark Zomelis from Novartis AG for India for Rs 93 crore

    Medical Dialogues Bureau4 Dec 2019 1:45 PM IST
    New Delhi: Drug firm Eris Lifesciences said it has acquired the trademark Zomelis and its associated trademarks from pharma major Novartis AG for the...
    DCGI directs all manufacturers to follow guidelines for uploading manufacturing sites and formulations on Sugam portal,details

    DCGI directs all manufacturers to follow guidelines for uploading manufacturing sites and formulations on Sugam portal,details

    Farhat Nasim3 Dec 2019 1:06 PM IST
    New Delhi: Communicating to all manufacturers about the Centre for Development for Advanced Computing (CDAC) guidelines for uploading various...
    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

    Sun Pharma updates on Ranbaxy Generic Drug Application Antitrust Litigation in US

    Farhat Nasim2 Dec 2019 11:28 AM IST
    On November 27, 2019, the US District Court (District of Massachusetts) entered a decision denying in part and granting in part Sun Pharma Ltd’s...
    Materiovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug Controllers

    Materiovigilance- Monitor all Adverse Reaction to Medical Devices, CDSCO directs State Drug Controllers

    Medical Dialogues Bureau1 Dec 2019 2:00 PM IST
    New Delhi: Through a recent notification, the Central Drugs Standard Control Organisation (CDSCO) has informed all the State Drug Controllers about...
    PrevNext

    Popular Stories

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Wellthy Therapeutics announces Rs 30 crore financing round led by Saama Capital

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok